Vascular anomalies in childhood. Review and update

Juan Carlos López Gutiérrez1, Jesús Pozo Losada2, Manuel Gómez Tellado3

  • 1Servicio de Cirugía Pediátrica, Hospital Universitario La Paz, Madrid, Spain.

Anales De Pediatria
|October 15, 2024
PubMed

Insights

Vascular anomalies, diverse conditions affecting blood vessels, significantly impact child quality of life. Accurate diagnosis and genetic insights are key for improved treatments and patient outcomes.

Area of Science:

  • Vascular biology and medicine
  • Paediatric pathology
  • Medical genetics

Background:

  • Vascular anomalies encompass over 150 subtypes affecting arteries, veins, capillaries, and lymphatics.
  • These conditions manifest from fetal development through early childhood, impacting quality of life and potentially causing severe complications.
  • Distinguishing vascular tumors from vascular malformations is crucial for accurate pediatric patient management.

Purpose of the Study:

  • To highlight the critical importance of differentiating vascular tumors from vascular malformations in pediatric patients.
  • To emphasize the need for a diagnostic algorithm based on thorough clinical evaluation.
  • To underscore the future role of genetic findings and therapeutic innovations in managing vascular anomalies.

Main Methods:

  • Clinical evaluation through detailed history-taking and physical examination.
  • Review of described subtypes and their varying prevalence.
  • Exploration of emerging therapeutic strategies and molecular targets.

Main Results:

  • Vascular anomalies present a wide spectrum of clinical manifestations and prevalences.
  • Accurate differentiation between vascular tumors and malformations is essential for appropriate treatment.
  • Rare vascular anomaly subtypes affect a significant population in the European Union.

Conclusions:

  • Effective management of vascular anomalies relies on precise diagnosis and tailored treatment approaches.
  • Future advancements in genetics and novel therapies hold promise for improving patient outcomes.
  • Continued research is vital to enhance life expectancy and quality of life for affected children.

Related Concept Videos

Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
2.7K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
3
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
533
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K